Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Business Transacted at the Annual General Meeting, 24 April 2023

The annual general meeting of LED iBond International A/S was held today in accordance with the previously announced agenda. The following resolutions were passed: 1. The Board of Director’s report on the activities of the company during the past financial year was noted. 2. The annual report was approved. 3. The proposal to transfer the profit for the year as stated in the annual report was adopted. 4. The proposal to grant discharge to the Board of Directors and the management was adopted. 5. The proposal for remuneration of the Board of Directors was adopted. 6. The

LKAB’s interim report for first quarter 2023 to be published on 27 April

LKAB’s interim report for the first quarter 2023 will be published on LKAB’s website at around 13.00 CEST on 27 April. The company’s Annual General Meeting will be held on the same day, along with related seminars.The report will be sent out as a press release and published at https://lkab.com/en/financial-information/. LKAB’s President and CEO Jan Moström will be available for comments by phone. Calls may be booked through Niklas Johansson, Senior Vice President Communication and Climate, on +46 10 144 52 19 or Frida Dagertun, Investor Relations, on +46 920 380 70. Annual General

Renal hyperfiltration: the underestimated risk factor for mortality

Renal hyperfiltration may be an underestimated risk factor for mortality, according to new research from the University of Eastern Finland.Conventionally, diminished kidney function is linked to chronic kidney disease and elevated risk of mortality. Renal hyperfiltration (RHF), or increased kidney function, has been largely dismissed as a normal observation in the general population and an expected manifestation of diabetes mellitus where it precedes renal decline. The condition, devoid of clinical manifestations, remains unknown to general medicine and is primarily screened and managed

Wellspect HealthCare pioneers use of renewable plastic in medical device industry

This week, Wellspect HealthCare, a MedTech business in Mölndal, Sweden, announced the introduction of bio-based raw materials into one of its products; a female urinary catheter with the name LoFric Elle. In an industry that is heavily reliant on fossil based raw materials for its plastic, the announcement raises the stakes for medical device manufacturers. “Finding more sustainable raw material sources to produce medical plastic devices is a game changer. By replacing fossil raw materials with bio-based raw materials, we reduce the end products’ environmental footprint without

Philippe Vimard joins Nordhealth's board of directors

24th April, 2023 - Nordhealth AS, a cloud-based practice management software provider for veterinary and therapy clinics, is proud to announce that Philippe Vimard will be joining its board of directors as of today. Mr. Vimard brings a wealth of experience to the Nordhealth board as a current board member and former COO and CTO at Doctolib, a leading healthcare software company in Europe. His background in technology and healthcare also includes roles as CTO at Klarna, a payment technology company in Sweden, COO and CTO at eDreams ODIGEO, an online travel group in Spain and CTO of Venere.

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 103 - 24 APRIL 2023 In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 40/23 and 42/23.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Thomas France, Investor Communications Partner, tel.: 3315 0451

DAMPSKIBSSELSKABET NORDEN A&S – weekly report on share buy-back

ANNOUNCEMENT NO. 102 -  24 APRIL 2023   On 13 February 2023, NORDEN initiated a share buy-back programme in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, (Safe Harbour regulation). The share buy-back programme runs from 13 February 2023 up to and including no later than 28 April 2023. For details, please see announcement no. 40 of 10 February 2023.   Under the share buy-back programme, NORDEN will purchase shares for up to a total of USD 50 million (approximately DKK 345

PEPTONIC Medical AB (publ) INTERIM REPORT  january – march 2023  (www.spotlightstockmarket.com, ticker: PMED)

· Significantly improved results · Continuous very positive development in core business Medical Consumer · Improved results but declining sales in business unit Lifestyle Consumer     GROUP 2022 FIRST QUARTER (jan-mar) · Net sales of products SEK 8 874 (8 908) thousand · Gross profit SEK 4 869 (5 596) thousand, 55% (63%) · Operating loss SEK -6 654 (-10 875) thousand · Loss per share -0,008 (-0,059) SEKWord from our CEO It is with great joy we can report that the positive development of the core business, clinically proven intimate self-care products,

Approval and publication of prospectus

COMPANY ANNOUNCEMENT Copenhagen, Denmark, April 24, 2023 – Brain+ A/S (Nasdaq First North: BRAINP)NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE. Brain+ A/S (“Brain+” or the “Company”) has prepared an EU growth prospectus (the “Prospectus”) relating to the Company’s

Arctic Bioscience – Mandatory notification of trade

Reference is made to the stock exchange release regarding approval of share capital increase, published 21st April 2023.Ronja Capital II AS, a legal person closely associated with a person discharging managerial responsibility in Arctic Bioscience, has today subscribed 943 833 shares, at a subscription price of NOK 17,27 per share. As part of the share capital increase process this subscription and capital increase will be registered in the Norwegian Register of Business Enterprises. Following the subscription and registration, Ronja Capital II AS will hold 3 087 999 shares in Arctic

EQL Pharma AB announces a revised unconditioned cash offer of SEK 8.40 per share to the shareholders of Sensidose Aktiebolag

This announcement is not an offer, neither directly or indirectly, in Australia, Belarus, Hong Kong, Japan, Canada, New Zealand, Russia, Singapore, South Africa or USA, or in any other jurisdiction where such offer pursuant to legislation, restrictions and regulations in such relevant jurisdiction would be prohibited by applicable law. Shareholders not resident in Sweden who wish to accept the Revised Offer (as defined below) must make inquiries concerning applicable legislation and possible tax consequences. Shareholders are referred to the offer restrictions included in the section titled "

BioBTX and Agilyx announce collaboration for the production of circular aromatic chemicals

· Aromatic chemicals (benzene, toluene, xylene) are one of the fundamental building blocks of the chemical industry · Account for ~40% of total petrochemicals by volume and worth ca. $200B/yrGRONINGEN, Netherlands and OSLO, Norway – April 24, 2023 – BioBTX B.V.  ("BioBTX"), the global leader in renewable aromatics technology, and Agilyx ASA  (OSE: AGLX; OTCQX: AGXXF) (“Agilyx” or “the company”), a leading post-consumer plastics recycling company have entered into a strategic collaboration to explore the scale-up of BioBTX technology at a

Fellow Bank changes its name. The new name is Alisa Bank.

ALISA BANK PLC PRESS RELEASE 24.4.2023 AT 10.00 EESTFellow Bank Plc is Alisa Bank Plc as of 21 April 2023. The new name better reflects the company’s vision to offer the smoothest everyday banking services for ordinary Finns as well as for small and medium-sized companies that need flexible financing. According to a survey conducted by the company, Finnish customers want a bank that above all has easy-to-use and comprehensive mobile banking services along with good customer service. People also appreciate an online bank with a clear layout and simple language. When building the new bank,

Notice to the Annual General Meeting of MilDef Group AB (publ)

Shareholders of MilDef Group AB (publ) are hereby summoned to the Annual General Meeting (AGM) to be held at 4 p.m. CEST on Thursday, 25 May 2023 at the company’s premises on Muskötgatan 6 in Helsingborg, Sweden.A. REGISTRATION AND NOTIFICATION Shareholders who wish to participate in the AGM must firstly be registered in the share register maintained by Euroclear Sweden AB on Tuesday 16 May 2023, and secondly notify the company of their intention to attend the AGM under the address MilDef Group AB, “Annual General Meeting”, P.O. Box 22079, SE-250 22 Helsingborg, Sweden, by e-mail

Berge Bulk and ABS Join Forces to Retrofit Bulk Carrier with Methanol Power

(SINGAPORE) A pioneering joint development project (JDP) to evaluate the feasibility of converting a bulk vessel to methanol fuel propulsion has been signed by ABS and Berge Bulk (BB). Berge Bulk CEO James Marshall and ABS Vice President of Global Sustainability Panos Koutsourakis signed the agreement which will see BB and ABS explore the possibility of retrofitting the 300-meter-long heavy fuel oil propelled bulk carrier BERGE MAUNA KEA to operate on methanol fuel. The six-month study is underway, and the two companies will collaborate on a broad range of

SPM and H2 Green Steel sign 5 year supply agreement for green steel

UK-based steel service center SPM (Steel Processing Midlands) has entered into a supply agreement with H2 Green Steel. The green steel will be delivered from H2 Green Steel’s flagship plant in northern Sweden and will amount to 25 percent of SPM’s annual volumes.Steel Processing (Midlands) Ltd is a privately owned steel and processing business with customers primarily in the automotive and construction industries based in the UK. H2 Green Steel was launched 2021 with a purpose to accelerate the decarbonization of hard-to-abate-industries, starting with steel. Construction of a modern and

Carbonhand® is now available to the US market

One of the most important milestones in the history of Bioservo Technologies has been achieved. The grip-strengthening glove Carbonhand is now available to the US market, and the process of establishing a commercial infrastructure of partner companies is initiated. The US accounts for about 42% of the world market for medical devices and the assessment is that Carbonhand, assisting individuals with weak hand function, has great potential to help many patients.  "Having the opportunity to present Carbonhand to the US market has been one of the most important milestones in the

Crunchfish provide perspectives on CBDC and payments

A special Central Bank Digital Currency (CBDC) supplement An Inflection Point for Global Payments: Industry Perspectives in 2023 has been released today to showcase case studies and perspectives from industry experts. Crunchfish provided the article Central banks should modernize payments. Who else would? This is also the topic of Crunchfish presentation in May 2023 at the upcoming Digital Currency Conference in Mexico City.   Currency Research  have today released An Inflection Point for Global Payments: Industry Perspectives in 2023 

The subscription period for Inhalation Sciences' rights issue begins today

Today on April 24, 2023, the subscription period begins in Inhalation Sciences Sweden AB (publ)’s ("ISAB" or the "Company") rights issue of shares (the “Rights Issue”). The Rights Issue was resolved by the Board of Directors on April 6, 2023, with support of the authorization from the Annual General Meeting on May 6, 2022. The subscription period runs until and including May 9, 2023.THIS DOCUMENT IS NOT TO BE DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, RUSSIA, BELARUS

Announcement of a Change in Shareholding According to Chapter 9, Section 10 of the Finnish Securities Market Act

Sitowise Group Plc Stock Exchange Release       24 April 2023 at 09.45 a.m. (EEST) Sitowise Group Plc (the "Company") has on 21 April 2023 received a notification in accordance with the Chapter 9, Section 10 of the Finnish Securities Market Act from Morgan Stanley & Co. International plc, according to which Morgan Stanley & Co. International plc's holding of the shares and votes of the Company has fallen below the threshold of 5 percent on 20 April 2023. According to the notification, Morgan Stanley & Co. International plc holds a total of 202,307 shares through financial instruments

poLight ASA: Last day of trading in Subscription Rights

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN CANADA, JAPAN, AUSTRALIA OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to previous stock exchange announcements from poLight ASA ("poLight" or the "Company") regarding a fully underwritten rights issue of 12,918,660 new shares in the Company (the "Offer Shares"), raising gross proceeds of NOK 135 million (the "Rights Issue"). The

The Board of Directors in Brain+ A/S has resolved on the previously announced intention to execute a rights issue of units

COMPANY ANNOUNCEMENT Copenhagen, Denmark, April 24, 2023 – Brain+ A/S (Nasdaq First North: BRAINP)NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE. The Board of Directors in Brain+ A/S (“Brain+” or the “Company”) has, with the mandated authorization from the extraordinary

Extended warranty for Rototilt machine couplers

Rototilt is introducing a two-year warranty on all new machine couplers delivered from 1 January 2023. As a result, the standard warranty is being extended from one to two years. “We set ourselves apart by calculating the warranty period from the delivery date, rather than limiting it to a maximum number of hours of use. Our machine couplers are robust and stable, which enables us to offer a two-year warranty,” says Jan Karlsson, Head of Orders and Aftermarket at Rototilt.The warranty is valid immediately on delivery, without any registration requirement. Rototilt also always offers a

There are no items matching the current filter
There are no more items matching the current filter
Back to top